الصفحة الرئيسية>>Signaling Pathways>> Immunology/Inflammation>> STING>>E7766 diammonium salt

E7766 diammonium salt

رقم الكتالوجGC62608

ملح الأمونيوم E7766 هو ناهض ستينج ذو جسور كبيرة مع Kd 40 نانومتر. يُظهر ملح ثنائي الأمونيوم E7766 أنشطة قوية للنمط الجيني الشامل ومضادة للأورام.

Products are for research use only. Not for human use. We do not sell to patients.

E7766 diammonium salt التركيب الكيميائي

Cas No.: 2242635-03-4

الحجم السعر المخزون الكميّة
1 mg
522٫00
متوفر
5 mg
1485٫00
متوفر
10 mg
2385٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

E7766 diammonium salt is a macrocycle-bridged STING agonist with a Kd of 40 nM. E7766 diammonium salt shows potent pan-genotypic and antitumor activities[1].

E7766 diammonium salt inhibits four human STING variants, human wild-type, HAQ, AQ and REF STING proteins, with EC50 values of 1 μM, 2.2 μM, 1.2 μM and 4.9 μM, respectively[1].

In murine colon cancer model, a single intratumoral injection of 10 mg/kg E7766 diammonium salt in the subcutaneous tumor. E7766 diammonium salt is shown to have potent antitumor activity with long lasting immune memory response in a mouse liver metastatic tumor model[1].

[1]. Dae-Shik Kim, et al. E7766, a Macrocycle-Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan-Genotypic Activity. ChemMedChem. 2021 Jun 7;16(11):1740-1743.

مراجعات

Review for E7766 diammonium salt

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for E7766 diammonium salt

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.